Published OCT 20, 2026

Established Functional & Naturopathic Medical Clinic, Utah

Utah

$2.2M
Revenue
$969K
SDE
3.0x
Multiple
Subscribe Free

Read the full deal writeup

Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.

Already a member? Sign in

Full Editorial Writeup

This is a Utah-based integrative medical clinic operating in the functional and naturopathic medicine space. The practice treats chronic health conditions by targeting root causes rather than managing symptoms, offering a stacked menu of cash-pay services including IV nutritional therapy, bioidentical hormone replacement therapy, regenerative medicine, functional immunology, and specialized oncology support. These are high-margin, repeat-visit services that build sticky patient relationships around ongoing protocols rather than one-and-done episodes.

The financials tell the real story here. On $2.23M of revenue the clinic throws off $969K of cash flow, a 43% owner-earnings margin that is exceptional for a medical practice and reflects the cash-pay, insurance-light nature of functional medicine. At a $2.9M ask and 2.99x multiple, the headline price is reasonable for a business generating nearly a million in annual cash flow, though the valuation hinges entirely on how much of that cash flow walks out the door when the treating provider leaves.

What makes this notable is the convergence of favorable demographics (aging boomers, hormone optimization, longevity obsession) with a cash-pay model that sidesteps insurance reimbursement headaches. The flip side is that functional and naturopathic medicine is discretionary spend: when household budgets tighten, elective IV drips and hormone optimization are among the first things patients cut. The durability of the revenue base is the central question a buyer must answer.

Why we like it

  • Earnings quality is the headline: $969K of cash flow on $2.23M of revenue is a 43% margin, which is rare for a medical practice and signals a cash-pay model with minimal insurance friction. Cash-pay revenue means no reimbursement delays, no denied claims, and no payer concentration, which materially de-risks the collections side of the business.
  • The service mix is naturally recurring. Hormone replacement, IV therapy, and functional immunology protocols pull patients back on monthly or quarterly cadences rather than one-off visits, creating a predictable base of repeat revenue that compounds as the panel grows.
  • Market tailwinds are real and multi-decade. Longevity medicine, hormone optimization, and root-cause functional care are among the fastest-growing niches in healthcare, driven by aging boomers and a cohort of affluent patients who increasingly pay out of pocket for care insurance will not cover.
  • An operator advantage exists for a buyer who can add providers and locations. The economics prove the unit model works, so a buyer with capital to recruit additional nurse practitioners or naturopaths can replicate the service menu and scale the panel without reinventing the clinical offering.
  • The 2.99x multiple on nearly $1M of cash flow is a fair entry point if the cash flow proves transferable. Compared to physician-dependent specialty practices that trade higher, the price leaves room for a buyer to earn a return even after accounting for some provider transition risk.

How to improve it

  • Audit and codify the clinical protocols in the first 90 days so the practice runs on documented systems rather than one provider's judgment. Converting tacit knowledge into standardized treatment pathways is the single biggest lever to de-risk a possible owner-provider departure and make the business transferable.
  • Launch a membership or subscription program around the recurring services like hormone optimization and IV therapy. A monthly membership converts episodic visits into contracted recurring revenue, smooths cash flow, and raises patient lifetime value while cushioning against discretionary pullback in downturns.
  • Build out provider capacity by recruiting additional naturopaths or nurse practitioners under the existing brand. The margin structure proves the model works, so adding clinical throughput is the fastest path to growing revenue without proportional overhead increases.
  • Invest in a structured patient reactivation and referral engine. Functional medicine patients are high-value and vocal advocates, so systematic win-back campaigns and referral incentives can lift panel size cheaply relative to paid acquisition.
  • Expand the ancillary revenue through branded supplements and at-home testing kits. Functional practices typically capture high-margin product sales alongside services, and formalizing a supplement dispensary adds recurring product revenue to the clinical base.
  • Evaluate a second location or satellite clinic once protocols are systematized. Geographic expansion within Utah leverages the proven service menu and brand, turning a single-site practice into a small multi-site group that commands a higher exit multiple.
  • Implement rigorous KPI tracking on patient acquisition cost, retention, and revenue per visit by service line. Most owner-run clinics lack this visibility, and clean dashboards both improve operating decisions and raise buyer confidence at your eventual exit.

Diligence notes

  • The central question is provider dependence: determine exactly who delivers the care and whether the cash flow survives the owner leaving. If a single treating physician or naturopath generates most of the revenue, the $969K number is largely personal goodwill and the valuation needs to be rebuilt around retention contracts or earnouts.
  • Scrutinize the regulatory and licensing posture of the specific services, especially regenerative medicine, oncology support, and BHRT. These areas draw heightened scrutiny from state medical boards and the FDA, so confirm all treatments, marketing claims, and compounding sources are fully compliant and that there are no pending complaints or investigations.
  • Validate the cash-pay revenue mix and verify there is no material insurance or Medicare exposure hiding in the numbers. Confirm the revenue is genuinely elective and patient-paid, review refund and chargeback history, and stress-test how resilient the panel would be in a consumer spending pullback given these are discretionary services.
  • Pin down years in business, patient panel size, retention rates, and revenue concentration by service line, none of which are disclosed. A practice overly reliant on one service (for example hormone therapy) or a small set of high-ticket patients carries more risk than diversified panel revenue.
  • Verify the add-backs behind the $969K cash flow figure and separate true owner discretionary earnings from provider compensation that a buyer would have to replace. If the owner is also the primary treating clinician, you must underwrite the cost of hiring a replacement provider, which can meaningfully compress the real operating margin.

Source

Originally listed on BizBuySell. View original listing →

Want the full analysis on every deal? Unlock the complete platform with Accredited Pro to screen live listings and read our operator-level writeups.